Keros Therapeutics (KROS) stock surges 22% amid strategic review for sale and the adoption of a poison pill to protect ...

In a dramatic twist of fortunes, the Phoenix Suns find themselves grappling with a daunting challenge this off-season. As they strive to bounce back from missing the playoffs for two consecutive years ...

Keros Therapeutics said on Thursday its board had authorized a stockholder rights plan, also known as a "poison pill", in response to rapid accumulations of the company's stock by some investors.

Keros Therapeutics has adopted a poison pill defense to fend off hostile takeovers, after some investors indicated a desire to influence the control of the drug developer. The poison pill, known as a ...

Republicans passed a blueprint for President Donald Trump’s “big, beautiful bill,” but the challenge is far from over. Speaker Mike ...

(Reuters) -Drug developer Keros Therapeutics said on Thursday its board has authorized a poison pill defense in response to some investors who have indicated "a desire to influence the control" of the ...

Those roads bypass or bulldoze straight through the historic heart of our small towns − ripping out the civic soul in the ...

"It's a speech test. Why don't we just call it that?" one of two Trump nominees says in 2nd Circuit oral argument, noting lax ...

In the leadup to the April 2 reconvened session, Youngkin handed down a laundry list of vetoes and bad-faith amendments to ...

Keros, which had a market capitalization of around $396 million based on Wednesday's closing price, said it will look at a range of options, including a sale or other business combination, continued ...

President Trump has made a habit of dropping major news when Israel’s Prime Minister Benjamin Netanyahu visits the White ...

The state Senate passed a bill that falls short of proposals put forward by Gov. Mike Braun, but the Republican signaled he's ...